Is levodopa toxic? Insights from pathological studies
The relationship between two pathological hallmarks of Parkinson’s disease (PD), i.e. selective loss of dopaminergic cells in the substantia nigra pars compacta (SNc) and intracytoplasmic aggregation of α-synuclein (αS) protein in Lewy bodies (LBs) in the surviving nerve cells, is still unresolved....
Main Authors: | Parkkinen, L, Lees, A |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Excerpta Medica
2013
|
Similar Items
-
Does levodopa accelerate the pathologic process in Parkinson disease brain?
by: Parkkinen, L, et al.
Published: (2011) -
Acute oral toxicity and biodistribution study of zinc aluminium-levodopa nanocomposite
by: Kura, Aminu Umar, et al.
Published: (2015) -
Characterization and toxicity of zinc aluminium layered double hydroxide-levodopa nanocomposite
by: Kura, Aminu Umar
Published: (2014) -
Release behaviour and toxicity evaluation of levodopa from carboxylated single-walled carbon nanotubes
by: Tan, Julia M., et al.
Published: (2015) -
Toxicity evaluation of zinc aluminium levodopa nanocomposite via oral routes in repeated dose study
by: Kura, Aminu Umar, et al.
Published: (2014)